Abstract
Aims :
To assess and compare the activity of pharmaceutical analysis on drug management in a geriatric acute care unit prior to and during the COVID-19 pandemic.
Methods :
This was a single-centre, observational, retrospective, and comparative cohort study. All Pharmacist Interventions (PIs) carried out in the unit between 27 January 2020 and 30 April 2020 were distinguished according to whether they were conducted prior to or during the first wave of COVID-19.
The main outcome measure was the rate of PIs per patient and per line of treatment analysed. Other data collected were the drug class managed by the PI, the Drug Related Problems (DRP) identified, the nature of the advice given, and the acceptance rate by geriatricians.